HGF and head and neck cancer: However, in most malignancies including lung, brain, gastric, colorectal, head and neck cancers, the HGF/c-Met pathway is dysregulated via multiple mechanisms, such as HGF binding, gene rearrangement, amplification, or mutation, thus promoting the activation of multiple downstream signalling pathways.7